Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55 (Q35914730)
Jump to navigation
Jump to search
scientific article published in August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55 |
scientific article published in August 2007 |
Statements
1 reference
Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55 (English)
1 reference
Bing Li
1 reference
Daniel J Allendorf
1 reference
Richard Hansen
1 reference
Jose Marroquin
1 reference
Daniel E Cramer
1 reference
Claire L Harris
1 reference
Jun Yan
1 reference
1 August 2007
1 reference
1 reference
7421-7430
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference